Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 23039668)

1.

Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.

Jahng GH, Xu S, Kim MJ.

Med Phys. 2012 Oct;39(10):6324-31. doi: 10.1118/1.4754655.

PMID:
23039668
2.

DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients.

Jahng GH, Xu S, Weiner MW, Meyerhoff DJ, Park S, Schuff N.

Neuroradiology. 2011 Oct;53(10):749-62. doi: 10.1007/s00234-011-0845-3. Epub 2011 Feb 22.

3.

Local susceptibility causes diffusion alterations in patients with Alzheimer's disease and mild cognitive impairment.

Jahng GH, Xu S.

Brain Imaging Behav. 2012 Sep;6(3):426-36. doi: 10.1007/s11682-012-9155-6.

PMID:
22415193
4.

Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease.

Seo EH, Lee DY, Lee JM, Park JS, Sohn BK, Lee DS, Choe YM, Woo JI.

PLoS One. 2013;8(1):e53922. doi: 10.1371/journal.pone.0053922. Epub 2013 Jan 15.

5.

Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele.

Kim SM, Kim MJ, Rhee HY, Ryu CW, Kim EJ, Petersen ET, Jahng GH.

Neuroradiology. 2013 Jan;55(1):25-34. doi: 10.1007/s00234-012-1077-x. Epub 2012 Jul 25.

PMID:
22828738
6.

Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Sep 15;58(2):469-80. doi: 10.1016/j.neuroimage.2011.05.083. Epub 2011 Jun 16.

PMID:
21718788
7.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

8.

Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.

Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junqué C, Solé-Padullés C, Peña-Gómez C, Bargalló N, Molinuevo JL, Bartrés-Faz D.

Neurobiol Aging. 2012 Jan;33(1):61-74. doi: 10.1016/j.neurobiolaging.2010.02.004. Epub 2010 Apr 3.

PMID:
20371138
9.

Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity.

Zhang Z, Liu Y, Jiang T, Zhou B, An N, Dai H, Wang P, Niu Y, Wang L, Zhang X.

Neuroimage. 2012 Jan 16;59(2):1429-40. doi: 10.1016/j.neuroimage.2011.08.049. Epub 2011 Aug 30.

PMID:
21907292
10.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

11.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

PMID:
15324364
12.

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.

Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB.

J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. Review.

PMID:
21971460
13.

Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging.

Ukmar M, Makuc E, Onor ML, Garbin G, Trevisiol M, Cova MA.

Radiol Med. 2008 Sep;113(6):915-22. doi: 10.1007/s11547-008-0286-1. Epub 2008 Jul 10.

PMID:
18618077
14.

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

Fellgiebel A, Wille P, Müller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P.

Dement Geriatr Cogn Disord. 2004;18(1):101-8. Epub 2004 Apr 14.

PMID:
15087585
15.

Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 15;56(2):766-81. doi: 10.1016/j.neuroimage.2010.06.013. Epub 2010 Jun 11.

PMID:
20542124
16.

Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.

Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RL, Neto MR.

Int Psychogeriatr. 2002 Mar;14(1):59-72.

PMID:
12094908
17.

A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up.

Scola E, Bozzali M, Agosta F, Magnani G, Franceschi M, Sormani MP, Cercignani M, Pagani E, Falautano M, Filippi M, Falini A.

J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):798-805. doi: 10.1136/jnnp.2009.189639. Epub 2010 Apr 14.

PMID:
20392973
18.

Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging.

Kiefer C, Brockhaus L, Cattapan-Ludewig K, Ballinari P, Burren Y, Schroth G, Wiest R.

Neuroimage. 2009 Dec;48(4):657-67. doi: 10.1016/j.neuroimage.2009.07.005. Epub 2009 Jul 14.

PMID:
19607926
19.

Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.

Zimny A, Bladowska J, Neska M, Petryszyn K, Guziński M, Szewczyk P, Leszek J, Sąsiadek M.

Med Sci Monit. 2013 Feb 4;19:86-94.

20.

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ; Alzheimer's Disease Cooperative Study.

Arch Neurol. 2004 Jan;61(1):59-66.

PMID:
14732621
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk